Quest Diagnostics benefits from an aging population, driving increased lab testing volumes, particularly in genetic testing, and offers a 2.0% dividend yield. DGX's M&A strategy, including the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback